Pharmacoeconomic investigations in intensive care
- 1 December 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 7 (6) , 460-463
- https://doi.org/10.1097/00075198-200112000-00016
Abstract
Financial constraints in health care in general and critical care services in particular have placed increasing demands upon health care professionals and decision-makers to ensure the highest quality of care with the best possible outcomes are attained for the least possible expenditure of resources. As such, pharmacoeconomic methods have become increasingly applied to pressing clinical problems to facilitate cost-effective delivery of health care services to the critically ill. This manuscript briefly details the basic tenets of pharmaco-economic analysis and provides an overview of recent applications to critical care issues.Keywords
This publication has 16 references indexed in Scilit:
- Pharmacoeconomic assessment of propofol 2% used for prolonged sedationCritical Care Medicine, 2001
- The impact of adverse patient occurrences on hospital costs in the pediatric intensive care unitCritical Care Medicine, 2001
- Association between Abciximab and Length of Stay in Intensive Care for Patients Undergoing Percutaneous Coronary InterventionPharmacoEconomics, 2000
- Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical careCritical Care Medicine, 2000
- Modelling for cost-effectiveness analysisStatistics in Medicine, 1999
- Financial impact of elimination of routine chest radiographs in a pediatric intensive care unitCritical Care Medicine, 1999
- How to use the results of an economic evaluationCritical Care Medicine, 1999
- Letter to the editorsHealth Economics, 1998
- Guidelines for Pharmacoeconomic StudiesPharmacoEconomics, 1997
- The economics and cost-effectiveness of critical care medicineIntensive Care Medicine, 1995